Jon Lim is a Partner who joined F-Prime Capital in 2011. Jon leads F-Prime’s investment efforts in Healthcare IT and Healthcare services, including F-Prime Capital’s investments in Liazon (acquired by Towers Watson), PatientPing, Kyruus, US HealthVest, Stride Health, TraceLink, VitalWare, WelbeHealth, Artemis Health, Protenus, Novaerus, and Procured Health. Most recently, Jon was a Principal at Polaris Partners, where he was part of the teams that led investments in several Software-as-a-Service companies (Phytel (acquired by IBM), Egnyte, Recurly, and KISSmetrics) as well as in Ocular Therapeutix (NASDAQ: OCUL) and SustainX. Jon began his investing career in 2002 as an Associate at Summit Partners, where his investments include MDVIP (acquired by Procter & Gamble) and Diagnostic Hybrids (acquired by Quidel). Jon also worked previously at Medtronic in their cardiac rhythm and disease management business.
Jon holds an M.B.A. from Harvard Business School and an A.B. in East Asian Studies from Harvard College, where he graduated magna cum laude.